Scientia Pharmaceutica is published by MDPI from Volume 84 Issue 3 (2015).
Articles in this Issue were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence.
Articles are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Austrian Pharmaceutical Society (Österreichische Pharmazeutische Gesellschaft, ÖPhG).
Sci. Pharm. 2010, 78(3), 594; https://doi.org/10.3797/scipharm.cespt.8.PDD05 (registering DOI)
Human Growth Hormone – Insights into its Aggregation Behavior using Denaturation Pathway Characterization
Research Center Pharmaceutical Engineering GmbH, Graz, Austria
Institute of Biotechnology and Biochemical Engineering, University of Technology Graz, Graz, Austria
Author to whom correspondence should be addressed.
Received: 12 July 2010 / Accepted: 12 July 2010 / Published: 12 July 2010
Abstract Protein denaturation processes involving aggregation are among the prime factors impeding the development of stable protein drug formulations. [...]
This is an open access article distributed under the Creative Commons Attribution License
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. (CC BY 4.0).
Share & Cite This Article
MDPI and ACS Style
WIESBAUER, J.; LEITGEB, S.; NIDETZKY, B. Human Growth Hormone – Insights into its Aggregation Behavior using Denaturation Pathway Characterization. Sci. Pharm. 2010, 78, 594.
WIESBAUER J, LEITGEB S, NIDETZKY B. Human Growth Hormone – Insights into its Aggregation Behavior using Denaturation Pathway Characterization. Scientia Pharmaceutica. 2010; 78(3):594.
WIESBAUER, J.; LEITGEB, S.; NIDETZKY, B. 2010. "Human Growth Hormone – Insights into its Aggregation Behavior using Denaturation Pathway Characterization." Sci. Pharm. 78, no. 3: 594.
Show more citation formats
Show less citations formats
[Return to top]
For more information on the journal statistics, click here
Multiple requests from the same IP address are counted as one view.